The global drug
discovery services market is foreseen to grow by 12.5%, from USD 15.75 Billion
in 2021 to USD 40.41 Billion in 2029. Growing R&D expenditure in the pharma
& biopharma industry, high cost of in-house drug development, increasing
demand for outsourcing analytical testing is to drive the market for the
upcoming forecast period. However, stringent regulations governing drug
discovery and animal usage remains one factor hindering the market growth over
the anticipated period.
Market Definition
What is Drug Discovery Services?
Drug discovery is the process through which potential new
medicines are identified. It involves a wide range of scientific disciplines,
including biology, chemistry and pharmacology.
Market Overview
The
drug discovery services market search study helps to thoroughly
understand the current trend in the market competitive analysis of the players
in the emerging market. Moreover, the DRO in the drug discovery services market
offers valuable perspicuity and a current scenario for making the right
decision. The research study covers the eminent players in the market with a
detailed analysis of the company and a financial overview containing their net
sales, business mix and geographical reach It mainly focuses on the key
developments of the products/services offered by the company in recent years.
Besides, we at Zettabyte have the expertise to analyses the global drug
discovery services market player's competitive landscape helping the client
comprehend their specific strategic growth approaches.
Drug discovery
services market study by "Zettabyte Analytics" offers details about
the market scope, market segmentation, technological advancement in the drug
discovery services market and highlights the optimistic, competitive landscape
and trends enduring over the years.
Major players in
the drug discovery services market include Aragen Life Sciences Pvt. Ltd.
(Formerly Gvk Biosciences Pvt. Ltd.), Charles River Laboratories International,
Inc., Curia Global Inc., Dalton Pharma Services, Domainex Ltd., Dr. Reddy’S
Laboratories Ltd. (Aurigene Discovery Technologies), Eurofins Scientific Se,
Evotec Se, Frontage Holdings Corporation, Genscript Biotech Corporation,
Jubilant Pharmova Limited, Laboratory Corporation Of America Holdings, Nuvisan
Pharma Holding Gmbh, Pharmaceutical Product Development, Inc., Pharmaron
Beijing Co., Ltd., Piramal Enterprises Limited, Promega Corporation, Selvita
S.A. (Formerly Selvita Cro S.A.), Shanghai Chempartner Co., Ltd., Shanghai
Medicilon Inc., Syngene International Limited, Tcg Lifesciences Pvt Ltd.,
Thermo Fisher Scientific, Viva Biotech (Shanghai) Ltd., Wuxi Apptec.
COVID-19 Impact on Global Drug
discovery services Market
The global impact
of COVID-19 has lost millions of lives with a massive cost to the healthcare
system. Moreover, the treatment cost for patients with COVID-19 has also had a
financial impact globally. the impact of COVID-19 on the drug discovery
services market has forced the companies to change their sourcing, pricing, and
promotion strategies. the drug discovery services market players are seen focusing
more on optimizing the e-commerce networks with the rising innovations in the
digital sector, which are creating new business models for the healthcare industry
player.
Research Scope
The report
provides market value for the base year 2021 and a yearly forecast from 2022 to
2029 in revenue (USD Million/ Billion). the market for each segment is present
in North America, Europe, Asia Pacific, Latin America, Middle East &
Africa, and the regional basis for the forecast mentioned above.
Key industry
dynamics, regulatory scenarios, major material dynamics and drug discovery
services market future markets are analyzed to understand their impact on demand
for the forecast period. growth rates have been estimated using correlation,
regression and time-series analysis.
Market Segmentation
For the purpose
of this report, the global drug discovery services market segmented on the
basis of product type, therapeutic area, process, end user, and region:
Product Type Outlook:
On the basis of
product type, the market is segmented into chemistry services, biology services.
Therapeutic Area Outlook:
On the basis of
therapeutic area, the market is segmented into cardiovascular diseases,
digestive system diseases, infectious and immune system diseases, neurology,
oncology, other therapeutic area.
Figure 1 Drug Discovery Services Market By Therapeutic
Area (Market Size And Forecast By Value - USD Million, 2021 & 2029)

Process Outlook:
On the basis of
process, the market is segmented into target selection, target validation,
hit-to-lead identification, lead optimization, candidate validation.
End Use Outlook:
On the basis of
end user, the market is segmented into academic institutes, pharmaceutical
& biotechnology companies, other end users.
Figure 2 End Use Outlook (Revenue, USD Million, 2021)

Regional Outlook (Revenue, USD million; 2021
& 2029)
Regional Outlook
(Revenue, USD million; 2018-2029)
|
North America
|
U.S.
|
|
Canada
|
Europe
|
Germany
|
|
U.K.
|
|
France
|
|
Spain
|
|
Italy
|
|
Rest of the Europe
|
Asia Pacific
|
India
|
|
Japan
|
|
China
|
|
South Korea
|
|
Australia
|
|
Rest of Asia-Pacific
|
Middle East & Africa
|
UAE
|
|
Saudi Arabia
|
|
South Africa
|
|
Rest of Middle East & Africa
|
Latin America
|
Brazil
|
|
Mexico
|
|
Argentina
|
|
Rest of Latin America
|
Figure 3 Drug Discovery Services Market:
Regional Dynamics
